The Guardian talks to runners on tirzepatide and sports dietitians, who warn appetite suppression can leave endurance athletes at risk of low energy availability.
Recap by typeshit. Full story at The Guardian.
The Washington Post looks at why so many users report shedding, a problem now nicknamed "Ozempic hair," and what new research suggests about the cause.
She says GLP-1 drugs slow how fast the stomach empties. That can let stomach contents reach the lungs during sedation, even after fasting.
The endocrinologist cautions that an interesting effect seen in animals does not mean a compound is suitable for human use.
The account calls the up to 28% weight loss impressive but says only about half of participants finished, citing nausea, constipation and skin sensitivity.
A former peptide chemist covered the AAPM conference as the FDA weighs letting pharmacies compound BPC-157 and others, and found sizable gaps in the evidence advocates cite.
He describes adding obesity, hormone and peptide therapy to his practice, and warns that many med spas lack real physician oversight.
Loading…